Skip to content
The Inflation Reduction Act (IRA), signed into law on August 16, offered historic investments in energy security and climate change. However, the legislation also […]
AZBio President: IRA could have ‘long-term, unintended consequences’ Read More »
With issues like Accelerated Approval, anti-vaccine legislation, and biomarkers being taken up in state capitals, these are busy times for patient advocates working at
State policies impacting access to innovative medicine, panel says Read More »
Today is the last chance to vote for the Pantheon Awards, sponsored by the state of California’s most impactful life sciences membership organization, California
Several BIO members up for the 2022 Pantheon Awards Read More »
In a monumental victory for the people in Oregon, biotech innovation, and the Biotechnology Innovation Organization (BIO), the Accelerated Approval pathway will be preserved
Oregon preserves Medicaid coverage for ‘Accelerated Approval’ drugs Read More »
The federal 340B Drug Pricing Program is starting to get a great deal of attention—for all the wrong reasons. The program was started in
Hospitals and pharmacies profit as 340B drives up patients’ drug costs Read More »
PDAB – which stands for Prescription Drug Affordability Board – is an acronym that you might hear more lately, as more and more states
PDABs bring the problem of drug price controls to the state level Read More »
The U.S. maternal mortality rate was 23.8 deaths per 100,000 live births as of 2020, an increase from 20.1 in 2019. And the maternal
Dobbs v. Jackson likely to increase maternal mortality – especially among Black mothers Read More »
A week before the August recess, Senate Democrats are pushing legislation containing anti-science drug pricing limits, which the biotech industry says will damage research
Price controls would ruin medical innovation, say state biotech organizations Read More »
The patchwork of state regulations regarding Medicaid coverage for new, innovative treatments can create barriers for patients seeking access to the most advanced therapies,
Report: State Medicaid policies can interfere with access to new treatments Read More »
More than two years on from COVID, offices and the world of work remain forever changed. Many companies are offering hybrid work models, where
How biotech recruiting has changed in the post-COVID world Read More »
